ReviewCureus2025
Robotics in Breast Surgery: Current Advantages, Disadvantages, and Applications.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Feasibility and outcomes of single-incision robotic nipple-sparing mastectomy: a systematic review and meta-analysis.Journal of robotic surgery · 2026Pooled it
- Endoscopic and Robotic Minimally Invasive Breast Surgery (MIBS) for Benign Breast Lesions: Our Experience of 80 Cases and Descriptive Comparison.European journal of breast health · 2026Article
- Evaluation of Surgeons' Perspectives and Perceived Readiness to Adopt Minimally Invasive Breast Surgery in a Low- and Middle-Income Setting.World journal of surgery · 2026Article
- Robotic and endoscopic minimally invasive breast surgery: a narrative synthesis on divergent global adoption and emerging trends.Journal of robotic surgery · 2026Review
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Breast cancer represents the most prevalent malignancy among women, requiring surgical procedures including mastectomies and lumpectomies. While conventional surgical procedures are typically more invasive, robot-assisted breast surgery has emerged as a minimally invasive alternative to traditional mastectomy and reconstruction techniques. Robotic systems offer enhanced precision, three-dimensional (3D) visualization, and improved ergonomics. Their primary objectives are to minimize invasiveness, optimize the surgeon's visibility, reduce postoperative complications, and achieve superior aesthetic outcomes. Robotic nipple-sparing mastectomy demonstrates oncological safety comparable to conventional methods, with lower overall complication rates. However, significant challenges persist, including high initial costs, longer operative times, and the imperative for specialized training. While robotic surgery enhances surgeon ergonomics and mitigates fatigue, further formal clinical studies are required to conclusively validate these benefits. Current applications encompass nipple-sparing mastectomies, sentinel lymph node biopsies, and breast reconstruction procedures. The document also explores robotic techniques for breast reconstruction, highlighting potential benefits such as reduced postoperative pain and improved aesthetic satisfaction. Despite promising preliminary results, more long-term oncological safety data and comprehensive cost-effectiveness analyses are essential for a complete evaluation of robotics' role in breast surgery. This review aims to summarize the current evidence on robotic-assisted breast surgery, focusing on its advantages, limitations, and clinical applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.